Stability Study Overview | Stability Zones In Pharma
In this post, we will go through the Stability Studies and stability zones in the Pharma industry. I know many people have too many questions regarding this
stability topic, but we will discuss it in fragments because stability
is a very vast topic.
In this post, we will see only the general look out
of the Stability study. for more details refer to my blogs as I tried to overlook all sides of stability study in different blogs.
What is a stability study?
We will see from the
scratch. Stability means how any material
is stable in some conditions. Here we look at the case of Finished
Product or Active Pharmaceutical Ingredient (API). How that Finished
Product or API is stable in some environmental conditions like
temperature, humidity, and light for some given period of time. Now Stability
Study means we Study the effect of such factors on the stability of Finished
Product or on API. Apart from these environmental factors like
temperature, humidity, and light some other factors also influence the quality
of product like container closure system, packaging material, the interaction
between API and excipient or within excipients.
why does this stability study is performed?
Now next question
is why do this stability study in the pharmaceutical industry?
The first reason for this is the regulatory requirement as we need to submit
this stability study data while we are filling a new product or API. Regulatory
authorities ask for the stability data. The second reason, there is a need for
this stability study is to identify the Stability of the finished product and
API from which one can find out the shelf life of the product. This study
gives us confidence in the stability of the product for a given period in such
conditions. This stability study data will be evidence of how the finished
product or API is varying according to the temperature, humidity, and light.
Here we are clear
about the basics of stability study actually what it is and why to do it? Now
we know that we have to do stability study but how to do it? This
is the general question may you rise in your mind. We don't need to think about
it because there are some regulatory guidelines by ICH that provide us detail
knowledge about how to do stability study. There are different guidelines for a
Stability study.
Q1A: Stability testing of new drug substances and
products
Q1B: Stability testing: Photostability testing of new drug substances and
products Q1C: Stability testing for new dosage forms
Q1D: Bracketing and matrixing designs for stability testing of new drug
substances and products
Q1E: Evaluation for stability data
Q1F: Stability testing of API and finished Pharmaceutical products (it withdrew
from the ICH website)
Most Readable Posts:
Types of Dosage Forms
Sterilization | Sterility Assurance Level
Difference Between Aseptic and Terminal Sterilization
apqr in pharmaStability Zones:
There are some
climatic zones of the ICH Stability Study. The world is divided into the following zones
depending upon its environmental condition.
Zone
|
Type of climate
|
Zone I
|
Temperate zone
|
Zone II
|
Mediterranean/
Subtropical zone
|
Zone III
|
Hot Dry zone
|
Zone IV a
|
Hot-Humid/ Tropical
zone
|
Zone IV b
|
Hot/ Higher Humid
zone
|
Depending upon zones
stability conditions for Long term Stability testing
Zone
|
Temperature
|
Humidity
|
Duration
|
Zone I
|
21 0C ± 2 0C
|
45 % RH ± 5
% RH
|
12 months
|
Zone II
|
25 0C ± 2 0C
|
60 % RH ± 5
% RH
|
12 months
|
Zone III
|
30 0C ± 2 0C
|
35 % RH ± 5
% RH
|
12 months
|
Zone IV a
|
30 0C ± 2 0C
|
65 % RH ± 5
% RH
|
12 months
|
Zone IV b
|
30 0C ± 2 0C
|
75 % RH ± 5
% RH
|
12 months
|
Refrigerated
|
5 ± 3 0C
|
No Humidity
|
12 months
|
Frozen
|
-15 ± 5 0C
|
No Humidity
|
12 months
|
Accelerated and Intermediate
Stability testing conditions:
Climatic Zone
|
Temperature
|
Humidity
|
Duration
|
Accelerated Ambient
|
40 0C ± 2 0C
|
75 % RH ± 5
% RH
|
6 months
|
Accelerated refrigerated
|
25 0C ± 2 0C
|
60 % RH ± 5
% RH
|
6 months
|
Accelerated Frozen
|
5 ± 3 0C
|
No Humidity
|
6 months
|
Intermediate
|
30 0C ± 2 0C
|
65 % RH ± 5
% RH
|
6 months
|
General Stability
Study conditions:
Study
|
Storage condition
|
Minimum period
|
Long term
|
25 0C ± 2 0C/
60 % RH ± 5 % RH or
|
12 months or 6 months
|
30 0C ± 2 0C/
65 % RH ± 5 % RH or
|
300C ± 2 0C/
75 % RH ± 5 % RH
|
Intermediate
|
30 0C ± 2 0C/
65 % RH ± 5 % RH
|
6 months
|
Accelerated
|
40 0C ± 2 0C/
75 % RH ± 5 % RH
|
6 months
|
Stability study
storage condition for refrigerated products:
Study
|
Storage condition
|
Minimum time period
|
Accelerated
|
25 0C ± 2 0C/
60 % RH ± 5 % RH or
|
6 months
|
30 0C ± 2 0C/
65 % RH ± 5 % RH or
|
300C ± 2 0C/
75 % RH ± 5 % RH
|
Long term
|
5 0C ± 3 0C
|
12 months or 6 months
|
Stability Study
Storage condition for Freezer:
Study
|
Storage condition
|
Minimum period
|
Long term
|
-20 0C ± 5 0C
|
12 months or 6 months
|
Stability Study Execution:
Now it's time to
select guidelines and prepare a detailed stability protocol for the stability
study. The protocol should contain,
- Title,
- Need/Scope of study,
- Any abbreviations and
definitions,
- Responsibilities,
- Packaging material details with vendor address,
- API details with vendor address,
- Sampling plan,
- Timepoint with stability
condition details,
- Details about which type of testing should carry out,
- Conclusion.
Execution of this protocol is carried out step by step. As per protocol Sampling is done. Sampled product is tested in the Quality Control lab and Microbiology lab on the initial stage. As given in protocol stability samples shall be kept in stability chambers according to given stability conditions and time period. On given period samples shall be withdrawn and tested. Product is analyzed stage-wise. During this stability study, the chamber's stability condition is monitored and recorded on daily basis. Any variation for more than 24 hours is reported and evaluated. After completion of all studies, the stability of the product is evaluated.
Stability study related more posts:
API Stability Study | Finished product | ICH Q1F Overview
Stability Study For New Drug Substances, Products | ICH Q1A (R2)
Stability Study Evaluation and Conclusion:
Evaluation of the Studied stability product is done on one summary report. This summary report should include the details of the product (Product name, Strength, Batch number, Batch size, Stability protocol number, Stability condition with time point), results of physical, chemical, biological, and microbiological tests, the Shelf life of the product, container closure system and storage condition. This summary report is the final conclusion of the stability study.
Comments
Post a Comment
If you have any doubt please let me know. Thank you.